Marino Stram & Associates’s ResMed RMD Stock Holding History

Marino Stram & Associates’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,511	Closed	-$372K	–	256
2021 Q2	$372K	Buy	+1,511	New	+$318K	0.1%	162

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marino Stram & Associates's RMD Position: Q3 2021 in Review

Marino Stram & Associates sold out of ResMed (RMD) in Q3 2021, closing a stake of 1,511 shares — an estimated $372K sold.

Marino Stram & Associates first reported a position in RMD in Q2 2021 and held it in 1 quarter. The position peaked at $372K in Q2 2021. 686 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

Marino Stram & Associates reported no remaining ResMed position as of Q3 2021 after selling out during the quarter.
Marino Stram & Associates sold 1,511 ResMed shares in Q3 2021, an estimated $372K.
Marino Stram & Associates first reported a position in ResMed in Q2 2021 and held it in 1 quarter.
Marino Stram & Associates's ResMed position peaked at $372K in Q2 2021.
686 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on Marino Stram & Associates's 13F filing for Q3 2021, filed 14 Oct 2021.